Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by ChaseYourDreamon Dec 08, 2016 10:31am
157 Views
Post# 25571144

RE:RE:RE:This may very well be

RE:RE:RE:This may very well be In my experience, you are correct about the danger of random questions in terms of relevance and clarity in the time available.... so it would be well for Vestor and Thor to have all these questions in writing to submit to management, and perhaps be shared aloud after receipt at management's discretion with attendees as questions that will be addressed systematically as a follow up. This could be in detail to the individual inquirer or in an NR if judged to be of material significance.

I am hearing  many useful niggling questions, but few that would not potentially confuse and distract rather than add to the collective understanding of others attending. KISS (Keep it simple, "stupid")


fredgoodwinson wrote: Hopefully the Presentations will follow the format of past years where Drs.Lilge and Kulkarni are allowed to give their Presentations largely unhindered followed by a few - hopefully highly relevant - questions taken from the floor.

Questions posed during the course of the Presentation rather then supplementary to it mean that the Presenter`s train of thought can easily be broken and we tend to end up learning less rather than more in the time available if these are little better than interruptions.


Bullboard Posts